Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 49, 2019 - Issue 12
251
Views
8
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Effects of liquorice on pharmacokinetics of aconitine in rats

ORCID Icon, , , , , , & show all
Pages 1485-1493 | Received 11 Dec 2018, Accepted 02 Feb 2019, Published online: 05 Mar 2019

References

  • Asghar A, Gorski JC, Haehner-Daniels B, Hall SD. (2002). Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampin. Drug Metab Dispos 30:20–26.
  • Bachmann KA, Ghosh R. (2001). The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions. Curr Drug Metab 2:299–314.
  • Chen H, Zhang X, Feng Y, et al. (2014). Bioactive components of Glycyrrhiza uralensis mediate drug functions and properties through regulation of CYP450 enzymes. Mol Med Rep 10:1355–62.
  • Chin KV, Pastan I, Gottesman MM. (1993). Function and regulation of the human multidrug resistance gene. Adv Cancer Res 60:157–80.
  • Choi JS, Choi JS, Choi DH. (2014). Effects of licochalcone A on the bioavailability and pharmacokinetics of nifedipine in rats: possible role of intestinal CYP3A4 and P-gp inhibition by licochalcone A. Biopharm Drug Dispos 35:382–90.
  • Gerin B, Dell’Aiera S, Richert L, et al. (2013). Assessment of cytochrome P450 (1A2, 2B6, 2C9 and 3A4) induction in cryopreserved human hepatocytes cultured in 48-well plates using the cocktail strategy. Xenobiotica 43:320–35.
  • He Y, Zhang JM, Gao F, et al. (2013). Advances and prospects on the combination mechanism for toxicity reduction and pharmacological effect improving between aconiti lateralis radix praeparata and glycyrrhizae radix et rhizoma (a classic TCM herb-pair). Pharm Clin Chin Mater Med 4:62–65.
  • He YF, Ci XY, Xie Y, et al. (2019). Potential detoxification effect of active ingredients in liquorice by upregulating efflux transporter. Phytomedicine 56:175–82.
  • Hou YC, Lin SP, Chao PD. (2012). Liquorice reduced cyclosporine bioavailability by activating P-glycoprotein and CYP3A. Food Chem 135:2307–12.
  • Li FY, Xie H, Weng L, et al. (2016). Effects of diammonium glycyrrhizinate on hepatic and intestinal UDP-Glucuronosyltransferases in rats: implication in herb-drug interactions. Chin J Nat Med 14:534–40.
  • Miao P, Qiu FR, Zeng J, et al. (2014). Antitoxin compatible mechanism of glycyrrhiza uralensis fisch. Inducing CYP3A to promote the metabolism of aconitum carmichaeliiDebx. Chin J Tradit Chin Med Pharm 29:2813–17.
  • Mu Y, Zhang J, Zhang S, et al. (2006). Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J Pharmacol Exp Ther 316:1369–77.
  • Nyirimigabo E, Xu Y, Li Y, et al. (2015). A review on phytochemistry, pharmacology and toxicology studies of aconitum. J Pharm Pharmacol 67:1–19.
  • Omura T. (1999). Forty years of cytochrome P450. Biochem Biophys Res Commun 266:690–8.
  • Pandit S, Ponnusankar S, Bandyopadhyay A, et al. (2011). Exploring the possible metabolism mediated interaction of Glycyrrhiza glabra extract with CYP3A4 and CYP2D6. Phytother Res 25:1429–34.
  • Paolini M, Barillari J, Broccoli M, et al. (1999). Effect of liquorice and glycyrrhizin on rat liver carcinogen metabolizing enzymes. Cancer Lett 145:35–42.
  • Singhuber J, Zhu M, Prinz S, Kopp B. (2009). Aconitum in traditional Chinese medicine: a valuable drug or an unpredictable risk? J Ethnopharmacol 12:18–30.
  • Smit JW, Schinkel AH, Müller M, et al. (1998). Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an Mdr1a gene disruption. Hepatology 27:1056–63.
  • Suzuki Y, Oyama T, Ishige A, et al. (1994). Antinociceptive mechanism of the aconitine alkaloids mesaconitine and benzoylmesaconine. Planta Med 60:391–4.
  • Tan H, Xu C, Zeng H, et al. (2016). SUMOylation of pregnane X receptor suppresses rifampicin-induced CYP3A4 and P-gp expression and activity in LS174T cells. J Pharmacol Sci 130:66–71.
  • Tang L, Ye L, Lv C, et al. (2011). Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes. Toxicol Lett 202:47–54.
  • Wang YG, Yang MH, Ma ZC, et al. (2009). Effects of 18β-glycyrrhizic acid and 18α-glycyrrhizic acid on mRNA and protein expression of cytochrome P4503A in cultured rat primary hepatocyte. Chin J Chin Mater Med 34:307–11.
  • Whyte-Allman SK, Hogue MT, Jenabian MA, et al. (2017). Xenobiotic nuclear receptors pregnane X receptor and constitutive androstane receptor regulate antiretroviral drug efflux transporters at the blood-testis barrier. J Pharmacol Exp Ther 363:324–35.
  • Yan G, Zhang H, Wang W, et al. (2017). Investigation of the influence of glycyrrhizin on the pharmacokinetics of celastrol in rats using LC-MS and its potential mechanism. Xenobiotica 47:607–13.
  • Yang M, Liu XB, Huang QD. (2003). The increasing effect and reducing effect principe of compatibility of radix aconite laterlis preparata and radix glycyrrhizae. Lish Med Mater Med Res 14:197–8.
  • Ye L, Tang L, Gong Y, et al. (2011a). Characterization of metabolites and human P450 isoforms involved in the microsomal metabolism of mesaconitine. Xenobiotica 41:46–58.
  • Ye L, Wang T, Yang C, et al. (2011b). Microsomal cytochrome P450 mediated metabolism of hypaconitine, an active and highly toxic constituent derived from Aconitum species. Toxicol Lett 204:81–91.
  • Ye L, Yang X, Yang Z, et al. (2013). The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells. Toxicol Lett 216:86–99.
  • Zhao Q, Wang Y, Wang H, Feng L. (2018a). Effects of glycyrrhizin on the pharmacokinetics of puerarin in rats. Xenobiotica 48:1157–63.
  • Zhao X, Wu Y, Wang D. (2018b). Effects of glycyrrhizic acid on the pharmacokinetics of pristimerin in rats and its potential mechanism. Eur J Drug Metab Pharmacokinet 43:63–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.